Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus

Biochemical and Biophysical Research Communications

Volumn 366, Issue 3, 2008, Pages 769-774

  Park, Ji Won ^a   Mok, Hyejung ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Adenovirus; Avidin and biotin interaction; EGF; Gene delivery; PEG

Indexed keywords

ADENOVIRUS VECTOR; AVIDIN; BIOTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCINE; GREEN FLUORESCENT PROTEIN; LIGAND; MACROGOL; RECOMBINANT EPIDERMAL GROWTH FACTOR; RHODAMINE;

ARTICLE; CANCER CELL; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MODIFICATION; DRUG CONJUGATION; DRUG SYNTHESIS; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS INACTIVATION; VIRUS PARTICLE;

ADENOVIRIDAE; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; EPIDERMAL GROWTH FACTOR; GENE TARGETING; GENETIC VECTORS; HUMANS; POLYETHYLENE GLYCOLS; TRANSFECTION;

ADENOVIRIDAE;

EID: 37549019328     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.045     Document Type: Article

References (30)

1. Majhen D., and Ambriovic-Ristov A. Adenoviral vectors-how to use them in cancer gene therapy?. Virus Res. 119 (2006) 121-133
2. Chandler L.A., Doukas J., Gonzalez A.M., Hoganson D.K., Gu D.L., Ma C., Nesbit M., Crombleholme T.M., Herlyn M., Sosnowski B.A., and Pierce G.F. FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol. Ther. 2 (2000) 153-160
3. Xu Z.L., Mizuguchi H., Sakurai F., Koizumi N., Hosono T., Kawabata K., Watanabe Y., Yamaguchi T., and Hayakawa T. Approaches to improving the kinetics of adenovirus-delivered genes and gene products. Adv. Drug Deliv. Rev. 57 (2005) 781-802
4. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
5. Fields B.N., Knipe D.M., and Howley P.M. Adenovirus: The Viruses and their Replication, Fields' Virology (2007), Wolters Kluwer Health/Lippincott Williams and Wilkins, Philadelphia (pp. 2111-2148)
6. Engelhardt J.F., Ye X., Doranz B., and Wilson J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91 (1994) 6196-6200
7. Yang Y., Trinchieri G., and Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1 (1995) 890-893
8. Dai Y., Schwarz E.M., Gu D., Zhang W.W., Sarvetnick N., and Verma I.M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92 (1995) 1401-1405
9. Mok H., Park J.W., and Park T.G. Microencapsulation of PEGylated adenovirus within plga microspheres for enhanced stability and gene transfection efficiency. Pharm. Res. 24 (2007) 2263-2269
10. O′Riordan C.R., Lachapelle A., Delgado C., Parkes V., Wadsworth S.C., Smith A.E., and Francis G.E. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10 (1999) 1349-1358
11. Croyle M.A., Yu Q.C., and Wilson J.M. Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum. Gene Ther. 11 (2000) 1713-1722
12. Gao J.Q., Eto Y., Yoshioka Y., Sekiguchi F., Kurachi S., Morishige T., Yao X., Watanabe H., Asavatanabodee R., Sakurai F., Mizuguchi H., Okada Y., Mukai Y., Tsutsumi Y., Mayumi T., Okada N., and Nakagawa S. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J. Control Release 122 (2007) 102-110
13. Alemany R., Suzuki K., and Curiel D.T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81 (2000) 2605-2609
14. Chillon M., Lee J.H., Fasbender A., and Welsh M.J. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 5 (1998) 995-1002
15. Mok H., Palmer D.J., Ng P., and Barry M.A. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol. Ther. 11 (2005) 66-79
16. Eto Y., Gao J.Q., Sekiguchi F., Kurachi S., Katayama K., Maeda M., Kawasaki K., Mizuguchi H., Hayakawa T., Tsutsumi Y., Mayumi T., and Nakagawa S. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J. Gene Med. 7 (2005) 604-612
17. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum. Gene Ther. 15 (2004) 1034-1044
18. Wickham T.J., Roelvink P.W., Brough D.E., and Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14 (1996) 1570-1573
19. Magnusson M.K., Hong S.S., Boulanger P., and Lindholm L. Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber. J. Virol. 75 (2001) 7280-7289
20. Parrott M.B., Adams K.E., Mercier G.T., Mok H., Campos S.K., and Barry M.A. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol. Ther. 8 (2003) 688-700
21. Henning P., Magnusson M.K., Gunneriusson E., Hong S.S., Boulanger P., Nygren P.A., and Lindholm L. Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum. Gene Ther. 13 (2002) 1427-1439
22. Bonsted A., Engesaeter B.O., Hogset A., Maelandsmo G.M., Prasmickaite L., D′Oliveira C., Hennink W.E., van Steenis J.H., and Berg K. Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J. Gene Med. 8 (2006) 286-297
23. Kim S.H., Jeong J.H., Mok H., Lee S.H., Kim S.W., and Park T.G. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from odn-peg-folate conjugate and cationic lipids. Biotechnol. Prog. 23 (2007) 232-237
24. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., and Haber D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350 (2004) 2129-2139
25. Mendelsohn J., and Baselga J. Epidermal growth factor receptor targeting in cancer. Semin. Oncol. 33 (2006) 369-385
26. Ono M., and Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin. Cancer Res. 12 (2006) 7242-7251
27. Lee H., Jang I.H., Ryu S.H., and Park T.G. N-terminal site-specific mono-PEGylation of epidermal growth factor. Pharm. Res. 20 (2003) 818-825
28. Green N.M. Avidin. Adv. Protein Chem. 29 (1975) 85-133
29. Green N.M. A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin. Biochem. J. 94 (1965) 23C-24C
30. Maizel Jr. J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36 (1968) 115-125